The application deadline for the online BioSpain 2021 Innovation AveNEW session has been extended to September 10. This is an opportunity for start-ups and emerging life sciences technology companies to gain additional visibility for their innovative ideas. Participation in the online BioSpain could result in a spot in the in-person Innovation AveNEW programmes at either the… Read More
The latest DDW Sponsored Sitting Down With podcast features Bryan Jones, Senior Research Fellow, BioTechnology Discovery Research, Eli Lilly and Co and Dan Bedinger, Application Science Team Lead, Carterra. Bamlanivimab was the first neutralising monoclonal antibody to receive emergency use authorisation from the FDA as a treatment for mild… Read More
The latest DDW Sponsored Sitting Down With podcast features Bryan Jones, Senior Research Fellow, BioTechnology Discovery Research, Eli Lilly and Co and Dan Bedinger, Application Science Team Lead, Carterra. Bamlanivimab was the first neutralising monoclonal antibody to receive emergency use authorisation from the FDA as a… Read More
The SLAS 2021 Building Biology in 3D Hybrid Symposium, originally planned for Jupiter, Florida, has been relocated to the Hilton La Jolla Torrey Pines in La Jolla, California, to enable current Covid-related safe meeting guidelines. “At this time, we cannot enforce SLAS safe meeting guidelines within the… Read More
BioIVT’s human AB serum product line is designed to supplement cell culture media and facilitate cell and gene therapy development. Human AB serum contains many compounds that are vital for cell growth, including growth factors, vitamins, nutrients, trace elements and transport factors. As a result, human… Read More
SK bioscience (SK) and GlaxoSmithKline (GSK) have initiated a Phase III clinical study of SK’s Covid-19 vaccine candidate, GBP510, in combination with GSK’s pandemic adjuvant following positive interim Phase I/II results. The randomised, active-controlled global trial will enrol around 4,000 participants from a range of countries and will aim to… Read More
Microbiome experts from Microba Life Sciences will discuss the next phase of discovery from the microbiome to a global audience via a series of webinars on September 15 (PST 10am-12pm | EST 1-3pm | CET 7pm). Professor Gene Tyson, Associate Professor Lutz Krause and Dr Alena Pribyl will discuss how advancements in metagenomic… Read More
The National Institutes of Health (NIH) has begun a clinical trial to assess the antibody response to an extra dose of an authorised or approved Covid-19 vaccine in people with autoimmune disease who did not respond to an original Covid-19 vaccine regimen. The trial will also investigate whether pausing… Read More
News round-up by DDW’s Megan Thomas for 23-27 August The Covid-19 pandemic has undoubtedly put virology back on the drug discovery map and this week, DDW’s Megan Thomas has rounded up five stories which show updates and advancements in the fight against the virus. … Read More
Register now for Neuroscience 2021, an SfN annual meeting where for the first time, the conference will have a hybrid format, featuring both virtual and in-person programming. A single registration fee will give attendees access to both formats. Neuroscience 2021 will take place November 8 -11 virtually, and November… Read More
The Institute of Cancer Research (ICR), London has discovered an investigational drug called NXP800, which cancer patients are set to receive for the first time. It was discovered in a Phase I clinical trial sponsored by an oncology-focused biopharmaceutical company, Nuvectis Pharma. The investigational oral drug inhibits the so-called… Read More
Inmagene Biopharmaceuticals and Affibody have dosed the first patient in the global ASPIRE Phase II trial evaluating izokibep (IMG-020 or ABY-035) for the treatment of ankylosing spondylitis (AS). “Dosing the first patient in the global Phase II AS trial is an important milestone for the izokibep programme,” said Dr. Jean-Louis Saillot, Inmagene’s Chief… Read More
Orgenesis has entered into a collaboration agreement with Savicell Diagnostics to deploy Savicell’s patented ImmunoBiopsy immunometabolism platform. The aim is to develop and validate diagnostic kits for enhanced quality control (QC) and monitoring purposes to be used by Orgenesis in manufacturing and processing of its cell and gene therapies. New assays will be developed to enhance the potency of cell and gene therapies… Read More
Japan has suspended the use of around 1.63 million doses of the Moderna vaccine due to contamination, which the health ministry confirmed resulted from “foreign materials” in an unused batch of roughly 560,000 vials, according to BBC reports. According to the news site, Takeda Pharmaceutical, which sells and distributes… Read More
McKinsey has mapped out 1,382 biotechs based in Europe and some interesting themes emerged, showing how European biotechs have established a position of strength from which to enter the industry’s next act. Over the past three years, Europe’s biotech industry has made meaningful progress on attracting capital and bringing products to market. Europe’s complex biotech… Read More
Moderna has completed the rolling submission process for its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for the full licensure of the its Covid-19 vaccine for active immunisation to prevent Covid-19 in individuals 18 years of age and older. As part of the completed BLA submission, Moderna has requested Priority… Read More
